Search Results - Joachim Labenz

Refine Results
  1. 1
    Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial

    Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo contr... by Joachim Labenz

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.

    Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. by Joachim Labenz, G Börsch

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Lifestyle factors and symptoms of gastro‐oesophageal reflux – a population‐based study

    Lifestyle factors and symptoms of gastro‐oesophageal reflux – a population‐based study by Marc Nocon, Joachim Labenz, Stefan N. Willich

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.

    Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. by Joachim Labenz, E Gyenes, G. H. Rühl, G Börsch

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The Diagnosis and Treatment of Functional Dyspepsia

    The Diagnosis and Treatment of Functional Dyspepsia by Ahmed Madisch, Viola Andresen, Paul Enck, Joachim Labenz, Thomas Frieling, Michael Schemann

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.

    Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled s... by Joachim Labenz, U Peitz, C Leusing, B Tillenburg, A. L. Blum, G Börsch

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.

    Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. by Joachim Labenz, M. Stolte, A.L. Blum, I Jorias, Friedhelm Leverkus, M Sollböhmer, J. Bertrams, G Börsch

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

    Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer by Joachim Labenz, B Tillenburg, U Peitz, JP Idström, Elena F. Verdú, M. Stolte, G Börsch, A.L. Blum

    Published 1996
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.

    Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. by Elena F. Verdú, David Armstrong, JP Idström, Joachim Labenz, M. Stolte, Gian Dorta, G Börsch, A. L. Blum

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

    S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) by H. Koop, Karl‐Hermann Fuchs, Joachim Labenz, Petra Lynen Jansen, Helmut Messmann, Stephan Miehlke, Wolfgang Schepp, Thomas Wenzl

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    High rate of post‐therapeutic resistance after failure of macrolide–nitroimidazole triple therapy to cure <i>Helicobacter pylori</i> infection: impact of two second‐line therapies in a randomized study

    High rate of post‐therapeutic resistance after failure of macrolide–nitroimidazole triple therapy to cure <i>Helicobacter pylori</i> infection: impact of two second‐line therapies... by U Peitz, M. Sulliga, K. Wolle, Andreas Leodolter, Ulrike von Arnim, Stefan Kahl, M. Stolte, G Börsch, Joachim Labenz, Peter Malfertheiner

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    [S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013].

    [S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013]. by H. Koop, K.-H. Fuchs, Joachim Labenz, Petra Lynen Jansen, Helmut Messmann, Stephan Miehlke, Wolfgang Schepp, T. G. Wenzl, Mitarbeiter der Leitliniengruppe

    Published 2014
    Artigo
    Save to List
    Saved in:
  13. 13
    Evolution of gastro‐oesophageal reflux disease over 5 years under routine medical care – the ProGERD study

    Evolution of gastro‐oesophageal reflux disease over 5 years under routine medical care – the ProGERD study by Peter Malfertheiner, Marc Nocon, Michael Vieth, M. Stolte, D Jaspersen, H. R. Koelz, Joachim Labenz, Andreas Leodolter, Tore Lind, Kai Richter, Stefan N. Willich

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study

    Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study by D Jaspersen, Michael Kulig, Joachim Labenz, Andreas Leodolter, Tore Lind, W. Meyer‐Sabellek, Michael Vieth, Stefan N. Willich, Dirk Lindner, M. Stolte, Peter Malfertheiner

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative

    Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative by Michael Kulig, Andreas Leodolter, Michael Vieth, Erika Schulte, D Jaspersen, Joachim Labenz, Tore Lind, W. Meyer‐Sabellek, Peter Malfertheiner, M. Stolte, Stefan N. Willich

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study

    A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study by Joachim Labenz, David Armstrong, K. Lauritsen, Peter Katelaris, Stephan Schmidt, K Schütze, Grzegorz Wallner, H. Juergens, Harold G. Preiksaitis, N. Keeling, Emma Nauclér, Stefan Eklund

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“

    Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“ by Alexander L. Gerbes, Joachim Labenz, Beate Appenrodt, Matthias Dollinger, Felix Gundling, Veit Gülberg, Axel Holstege, Petra Lynen-Jansen, Christian J. Steib, Jonel Trebicka, Reiner Wiest, Alexander Zipprich

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“

    Aktualisierte S2k-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) „Komplikationen der Leberzirrhose“ by Alexander L. Gerbes, Joachim Labenz, Beate Appenrodt, Matthias Dollinger, Felix Gundling, Veit Gülberg, Axel Holstege, P. Lynen-Jansen, Christian J. Steib, Jonel Trebicka, Reiner Wiest, Alexander Zipprich

    Published 2019
    Get full text
    Errata/Corrigenda
    Save to List
    Saved in:
  19. 19
    Proton Pump Inhibitors: Rational Use and Use-Reduction – The Windsor Workshop

    Proton Pump Inhibitors: Rational Use and Use-Reduction – The Windsor Workshop by Peter J. Kahrilas, Foteini Anastasiou, Albert J. Bredenoord, Hashem B El Serag, Joachim Labenz, Juan Mendive, Edoardo Savarino, Daniel Sifrim, Mihaela Udrescu, Rena Yadlapati, A. P. S. Hungin

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    S3-Leitlinie Divertikelkrankheit/Divertikulitis – Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

    S3-Leitlinie Divertikelkrankheit/Divertikulitis – Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deut... by Ludger Leifeld, Christoph‐Thomas Germer, Stephan Böhm, Franz Ludwig Dumoulin, Thomas Frieling, Martin E. Kreis, Alexander Meining, Joachim Labenz, Johan Friso Lock, Jörg‐Peter Ritz, A. Schreyer, Wolfgang Kruis

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: